Editorial Policies

Focus and Scope

The Chemical Biology Letter is an international journal that provides a rapid forum for publication of quality original research at the interface of chemistry and biology. Chemical biology letters covers the scientific ideas and approaches of chemistry, biology and allied interdisciplinary areas such as medicinal chemistry, drug discovery, drug delivery, biosensor, protein chemistry, biological chemistry, biomolecules, bio-technology, biomedical, molecular biology and other allied areas covering chemistry and biology for the better understanding of biological phenomenon at molecular level. The journal accepts research articles from the community of chemical biologists.

Section Policies

Research Articles

Regular Research Article

Open Submissions

Indexed

Peer Reviewed

Review Article

Review article related to chemistry biology interface.

Open Submissions

Indexed

Peer Reviewed

Short Communications

Short Communications/Letters from Chemical Biology.

Open Submissions

Indexed

Peer Reviewed

Nuclear Medicine - Special Issue

The section is meant for articles (research, review and short communications) for special issue on Nuclear Medicine.

Editors

Anil Mishra

Open Submissions

Indexed

Peer Reviewed

Peer Review Process

The journal uses ‘Single Blind Review’ of the manuscripts: Reviewer may see the author details, while identity of reviewers is not disclosed to authors. The reviewers must maintain the confidentiality during reviewing and post review of manuscript. The manuscript work should be evaluated in respective field of expertise and detailed feedback and recommendation should be provided to editors.

On average, submitted manuscripts would be reviewed by three independent reviewers.

Average time to review and submit recommendation by reviewer for article manuscripts is three weeks.

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Purchase Article: 24.00 (USD)

The payment of this fee will enable you to view, download, and print this article.

About CBL

The Chemical Biology Letters is a top-tier venue for discoveries at the interface of chemistry and biology, chemical biology, synthetic biology, and in basic and applied biomedical research covering recent advances in drugs and therapeutics development. The CBL:

would provide all contents on online site for wide circulation and get contents indexed in different scientific content databases.

provides free access to all of its research articles for one or more months for each issue,

would deposit published research articles in different databases and would satisfy the NIH Public Access Policy guidlines.

is an ideal home for authors seeking the broadest audience for their most important work.

The journal is led by Editors and supported by Editorial Advisory Board of peer scientists from various reputed universities, research institutes and other reputed Medical Research Institutes whose depth and experience ensure fair and competent peer review.

Sending your work to the CBL

The journal considers research submissions in several categories. The CBL receives submissions only through its website; submissions by mail or e-mail will be returned.

When a manuscript is received and confirmed by the CBL, an acknowledgment is sent via e-mail to the corresponding author. For any communication with us, please reference the tracking number assigned by the CBL noted in the acknowledgment.

In order to avoid confusion regarding correspondence, inquiries, and decisions, the CBL will typically communicate only with those who are designated as corresponding authors during the submission process.

Manuscript submitted and processed for reviewing can't be withdrawn. If authors donot respond to emails for the reviewed and accepted manuscript, then the article will be published by the journal in as such format with a note 'withdrawn by authors' by no response.

Further, the journal publishes biomedical reports, so the journal adheres and follows the guidelines defined for publication in medical journals by International Committee of Medical Journal Editors (ICMJE) in its document ‘Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals’ provided on link http://www.icmje.org/recommendations and World Association of Medical Editors (WAME) on its webpage http://www.wame.org/

The Authors, Reviewers and Editors are expected to adhere and follow the code of conduct on ethical practices defined at above mentioned links in the respective roles.

The manuscript processing involves following stages

In addition, general instructions and help pages on ‘Integrated Science’ for Authors, Reviewers and Editors should be referred for brief general conduct

Authors

Each authors who submit (and willing to publish in the journal) the manuscript, should read the ethical guidelines for submission and publication of work in scientific and medical journal (listed on above links). Particularly, manuscript must be plagiarism free. Any Animal study reported should have been performed with approval of respective institutional ethical committee and statement thereof should be included in manuscript.

The journal uses ‘Single Blind Review’ of the manuscripts, the reviewers must maintain the confidentiality during reviewing and post review of manuscript. The manuscript work should be evaluated in respective field of expertise and detailed feedback and recommendation should be provided to editors. The general code of conduct defined in above links should be referred and followed while reviewing and providing feedback.

All the editors should handle the assigned manuscripts by observing fair processing of submissions, editorial independence, confidentiality, and rational decision making within stipulated time framework with the feedback obtained from independent reviewer/experts in the field of work covered in respective manuscript. A detailed code of conduct mentioned in above reference documents should be adhered to.

The Publisher ‘Integrated Science’ handles the unethical publishing cases. In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism, the publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification or, in the most severe case, the retraction of the affected work. The publisher, together with the editors, shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, and under no circumstances encourage such misconduct or knowingly allow such misconduct to take place.

Access to journal content: The publisher is committed to the permanent availability and preservation of scholarly research. The online and digital contents are preserved by the Publisher by maintaining own digital archive and would also ensure accessibility by partnering with other digital archiving organizations. Most of the journal contents are archived in the Print form as well.